The Predictive Value of Serum Fibrinogen and Platelet Distribution Width for Long-term Cardiac Death in Acute Myocardial Infarction Patients

Overview

Journal J Thorac Dis

Publisher AME Publishing Company

Specialty Pulmonary Medicine

Date 2024 Sep 13

PMID 39268112

Authors

Zhen-Fa Zhou

Cui-Fen Hu

Mei-Fang Gao

Xian Jin

Yu Chen

Di Wang

Cheng-Xing Shen

Liang Liu

Affiliations

Soon will be listed here.

Abstract

Background: Acute myocardial infarction (AMI) is the most severe manifestation of coronary heart disease (CHD), and timely and effective opening of the culprit vessels has been effective in reducing its mortality, but long-term death still threatens the life of patients. Therefore, finding biomarkers to predict death post-myocardial infarction (MI) is crucial. The aim of our study is to find biomarkers that predicted long-term death in Chinese AMI patients.

Methods: This retrospective analysis included patients with AMI from 1 January 2017 to 30 September 2019. All patients were followed up at least 4 years. Propensity score matching was used to mitigate the influence of nonrandom selection in MI-survival and MI-death groups. Cox analysis was applied for analyzing the risk factors of death post-MI. The receiver operating characteristic (ROC) curve was used to analyze the predictive value of biomarkers.

Results: Of the 1,059 AMI patients analyzed, 130 died during follow-up. After propensity matching, there were 116 patients in each of the two groups. In addition to the traditional risk factors for long-term death post-MI, two important risk factors platelet distribution width (PDW) [hazard ratio (HR) =1.210, 95% confidence interval (CI): 1.080-1.356, P=0.001] and fibrinogen (HR =1.218, 95% CI: 1.027-1.444, P=0.02) were found. The area under the curve (AUC) of PDW and fibrinogen was 0.604 (P=0.007) and 0.684 (P<0.001) respectively. The optimal thresholds were 13.05% and 3.562 g/L respectively.

Conclusions: PDW and fibrinogen seem to be useful as biomarkers for long-term death prediction post-MI. The current research provides new insight into the prevention and treatment of death in Chinese patients post-MI.

Citing Articles

miRNAs and Hematological Markers in Non-Alcoholic Fatty Liver Disease-A New Diagnostic Path?.

Michalak A, Guz M, Kozicka J, Cybulski M, Jeleniewicz W, Telejko I Biomedicines. 2025; 13(1).

PMID: 39857813 PMC: 11762403. DOI: 10.3390/biomedicines13010230.

References

Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I . Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia. 2010; 14(1):28-32. PMC: 2843567. View

Boggon R, Timmis A, Hemingway H, Raju S, Mondello Malvestiti F, van Staa T . Smoking cessation interventions following acute coronary syndrome: a missed opportunity?. Eur J Prev Cardiol. 2012; 21(6):767-73. PMC: 4475793. DOI: 10.1177/2047487312460517. View

Mahmud E, Ramsis M, Behnamfar O, Enright K, Huynh A, Kaushal K . Effect of Serum Fibrinogen, Total Stent Length, and Type of Acute Coronary Syndrome on 6-Month Major Adverse Cardiovascular Events and Bleeding After Percutaneous Coronary Intervention. Am J Cardiol. 2016; 117(10):1575-1581. DOI: 10.1016/j.amjcard.2016.02.032. View

Retterstol L, Kierulf P, Pedersen J, Bohn M, Bakken A, Erikssen J . Plasma fibrinogen level and long-term prognosis in Norwegian middle-aged patients with previous myocardial infarction. A 10 year follow-up study. J Intern Med. 2001; 249(6):511-8. DOI: 10.1046/j.1365-2796.2001.00837.x. View

Timoteo A, Papoila A, Lousinha A, Alves M, Miranda F, Ferreira M . Predictive impact on medium-term mortality of hematological parameters in Acute Coronary Syndromes: added value on top of GRACE risk score. Eur Heart J Acute Cardiovasc Care. 2014; 4(2):172-9. DOI: 10.1177/2048872614547690. View

Sullivan S, Young A, Garcia M, Almuwaqqat Z, Moazzami K, Hammadah M . Sex Differences in Vascular Response to Mental Stress and Adverse Cardiovascular Events Among Patients With Ischemic Heart Disease. Arterioscler Thromb Vasc Biol. 2023; 43(4):e112-e120. PMC: 10164352. DOI: 10.1161/ATVBAHA.122.318576. View

Schwalm J, Mckee M, Huffman M, Yusuf S . Resource Effective Strategies to Prevent and Treat Cardiovascular Disease. Circulation. 2016; 133(8):742-55. PMC: 4766731. DOI: 10.1161/CIRCULATIONAHA.115.008721. View

Gawaz M, Langer H, May A . Platelets in inflammation and atherogenesis. J Clin Invest. 2005; 115(12):3378-84. PMC: 1297269. DOI: 10.1172/JCI27196. View

Wei S, Mao L, Liu B, Zhong L . Serum biomarkers and the prognosis of AMI patients. Herz. 2013; 39(3):384-9. DOI: 10.1007/s00059-013-3828-9. View

10.

Bekler A, Ozkan M, Tenekecioglu E, Gazi E, Yener A, Temiz A . Increased Platelet Distribution Width Is Associated With Severity of Coronary Artery Disease in Patients With Acute Coronary Syndrome. Angiology. 2014; 66(7):638-43. DOI: 10.1177/0003319714545779. View

11.

Ulucan S, Keser A, Kaya Z, Katlandur H, Ozdil H, Bilgi M . Association between PDW and Long Term Major Adverse Cardiac Events in Patients with Acute Coronary Syndrome. Heart Lung Circ. 2015; 25(1):29-34. DOI: 10.1016/j.hlc.2015.05.017. View

12.

Ngo T, Moufarrej M, Rasmussen M, Camunas-Soler J, Pan W, Okamoto J . Noninvasive blood tests for fetal development predict gestational age and preterm delivery. Science. 2018; 360(6393):1133-1136. PMC: 7734383. DOI: 10.1126/science.aar3819. View

13.

Byrne R, Rossello X, Coughlan J, Barbato E, Berry C, Chieffo A . 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023; 44(38):3720-3826. DOI: 10.1093/eurheartj/ehad191. View

14.

Ang L, Mahmud E . Monitoring oral antiplatelet therapy: is it justified?. Ther Adv Cardiovasc Dis. 2009; 2(6):485-96. DOI: 10.1177/1753944708094736. View

15.

Uluganyan M, Karaca G, Ulutas T, Ekmekci A, Tusun E, Murat A . The Impact of Admission Serum Creatinine Derived Estimated Glomerular Filtration Rate on Major Adverse Cardiac Events in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention. J Clin Med Res. 2016; 8(4):325-30. PMC: 4780496. DOI: 10.14740/jocmr2482w. View

16.

von Lueder T, Girerd N, Atar D, Agewall S, Lamiral Z, Kanbay M . Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative. Eur J Heart Fail. 2015; 17(11):1144-51. DOI: 10.1002/ejhf.419. View

17.

Verdoia M, Barbieri L, Schaffer A, Cassetti E, Di Giovine G, Bellomo G . Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention. J Thromb Thrombolysis. 2013; 37(3):345-52. DOI: 10.1007/s11239-013-0954-4. View

18.

Xu W, Wang L, Zhang R, Sun X, Huang L, Su H . Diagnosis and prognosis of myocardial infarction on a plasmonic chip. Nat Commun. 2020; 11(1):1654. PMC: 7125217. DOI: 10.1038/s41467-020-15487-3. View

19.

Li N, Chen R, Li J, Zhao X, Wang Y, Zhou J . Prognostic significance of serial N-terminal pro-B-type natriuretic peptide levels in patients with acute myocardial infarction: A prospective study. Am Heart J. 2023; 262:90-99. DOI: 10.1016/j.ahj.2023.04.015. View

20.

Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G . Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984; 311(8):501-5. DOI: 10.1056/NEJM198408233110804. View